PPP: Fueling research and development

November 14, 2011 | Monday | News

In this issue of BioSpectrum the Public Private Partnership Case Study Series showcases the work of an organization, set up under public-private partnership, in sequencing and analyzing the genome of a higher organism. The other two companies featured have utilized funding by the government to find home-grown solutions to expensive and imported vaccine and diagnostic kit.

Ganit Labs, a public-private partnership between Strand Life Sciences and the Institute of Bioinformatics and Applied Biotechnology, sequenced and analyzed the entire genome of Neem tree
With BIPP funding, Amar Immunodiagnostics finds an answer to the imported and expensive diagnostic kits for autoimmune diseases
Tergene Biotech uses Department of Biotechnology's help to develop a vaccine for pneumonia that is more affordable

PPP: Fueling research and development

Comments

Thank You

Trending Topics

SCRMP announces Annual International Conference 2025 at Medicaps University

Govt backs India’s first indigenous thrombectomy device by S3V Vascular Technologies

Agilent unveils next generation in LC-Mass detection- The InfinityLab Pro iQ Series

Mapmygenome goes global with acquisition of Microbiome Insights

Most Read

India partners with WHO to mainstream Ayush globally

Vgenomics and Dr. Shroff's Eye Hospital jointly develop unique biomarker to detect Keratoconus

MAHE and BPL Medical Technologies forge strategic partnership to advance medical device innovation

PM Narendra Modi announces launch of Wadhwani Hub and Wadhwani Innovation and Translation Centre at IIT-B

Survey Box

Contact Us

Enquiry

Subscribe to BioSpectrum India

PPP: Fueling research and development

Comments

Thank You

Trending Topics

Most Read

Survey Box

Have an Account?